MedReleaf Australia - Medicinal Cannabis Products

INVESTOR ENQUIRIES

To discuss investment in MedReleaf Australia and to receive our Investor Brief and Information Memorandum documentation, please contact one of the company representatives below.

Russell Harding – Executive Chairman & CEO
Email: rharding@medreleafaustralia.com.au

Nathan Davis – Head of Strategy and Business Development
Email: ndavis@medreleafaustralia.com.au

For Correspondence:

MedReleaf Australia
GPO Box 2846
Brisbane QLD 4001

INVESTOR ENQUIRIES

For Correspondence:

Make an enquiry